Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement
Status:
Withdrawn
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
In this prospective pilot study without control group children and young adults (10-25 years
old) diagnosed with Bardet-Biedl syndrome and treated with Metformin for their adipositas
will be evaluated for a possible additional effect of Metformin on visual acuity.